Nothing Special   »   [go: up one dir, main page]

JPH08134048A - Production of oxazolines - Google Patents

Production of oxazolines

Info

Publication number
JPH08134048A
JPH08134048A JP27347594A JP27347594A JPH08134048A JP H08134048 A JPH08134048 A JP H08134048A JP 27347594 A JP27347594 A JP 27347594A JP 27347594 A JP27347594 A JP 27347594A JP H08134048 A JPH08134048 A JP H08134048A
Authority
JP
Japan
Prior art keywords
group
formula
reaction
methyl
lewis acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27347594A
Other languages
Japanese (ja)
Inventor
Hideyuki Ikehira
平 秀 行 池
Masao Yanagawa
川 正 生 柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP27347594A priority Critical patent/JPH08134048A/en
Publication of JPH08134048A publication Critical patent/JPH08134048A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PURPOSE: To obtain the subject compound by using a water-containing reaction raw materials and catalyst as it is without drying and dehydrating in advance by reacting a specific nitrile with an amino alcohol in the presence of a Lewis acid, etc. CONSTITUTION: The objective compound of formula II (e.g. 2-methyl-4- phenyloxazoline) is produced by reacting (A) a nitrile of the formula R<1> -CN [R<1> is a (substituted)alkyl, an aralky] or an aryll (e.g. acetonitrile) with (B) an amino alcohol of formula I [R<2> to R<5> are each H, a (substituted)alkyl, an aralkyl or an aryl] (e.g. 2-aminoethanol) in the presence of (C) a Lewis acid (e.g. aluminum trichloride) and (D) a molecular sieve in a solvent (e.g. toluene) at 60-150 deg.C. Preferably, the molar ratio of A:B is (0.5-2):1 and the amounts of the components C and D are 0.1-3 times mol and 0.5-10 times weight based on the component B, respectively.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、オキサゾリン類の製造
法に関する。
TECHNICAL FIELD The present invention relates to a method for producing oxazolines.

【0002】[0002]

【従来の技術】オキサゾリン類は医薬、農薬、機能性材
料などの中間体として公知であり、その製造法として、
ニトリル類とアミノアルコール類とを酢酸亜鉛などの触
媒の存在下に、反応系内の水分含量を1.0重量%以下
に維持して反応させる方法(特開平5−140129号
公報)が知られている。
2. Description of the Related Art Oxazolines are known as intermediates for medicines, agricultural chemicals, functional materials and the like.
A method is known in which nitriles and amino alcohols are reacted in the presence of a catalyst such as zinc acetate while maintaining the water content in the reaction system at 1.0% by weight or less (JP-A-5-140129). ing.

【0003】しかし、この方法による場合には、反応系
内の水分含量の維持のために、予め各反応原料や触媒を
乾燥させて脱水しなければならず、工業的製造法として
有利な方法とは言えなかった。また、この方法において
はラセミあるいは光学活性なオキサゾリン類の製造に関
しては全く認識されていなかった。
However, in the case of this method, in order to maintain the water content in the reaction system, each reaction raw material or catalyst must be dried and dehydrated in advance, which is an advantageous method as an industrial production method. I couldn't say. Further, in this method, there was no recognition about the production of racemic or optically active oxazolines.

【0004】[0004]

【発明が解決しようとする課題】このようなことから、
本発明者らは、ニトリル類とアミノアルコール類との反
応において、水分を含んでいる反応原料や触媒を反応前
に予め乾燥、脱水することなく、そのまま使用しても容
易に反応が進行し、また分子中に不斉炭素を有するラセ
ミあるいは光学活性なオキサゾリン類についても容易に
製造できる方法について検討の結果、本発明に至った。
DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention
The present inventors, in the reaction of nitriles and amino alcohols, the reaction raw material or catalyst containing water is not dried in advance before the reaction, without dehydration, the reaction easily proceeds as it is, Further, as a result of studying a method for easily producing racemic or optically active oxazolines having an asymmetric carbon in the molecule, the present invention has been completed.

【0005】[0005]

【課題を解決するための手段】本発明は、一般式3 R1 −CN (式中、R1 は置換基を有していてもよいアルキル基も
しくはアラルキル基もしくはアリール基を示す。)で示
されるニトリル類と、一般式2 (式中、R2 、R3 、R4 およびR5 は同一または相異
なって水素原子、置換基を有していてもよいアルキル基
もしくはアラルキル基もしくはアリール基を示す。)で
示されるアミノアルコール類とを、ルイス酸およびモレ
キュラーシーブの共存下に反応させることを特徴とする
一般式1 (式中、R1 、R2 、R3 、R4 およびR5 は前記と同
じ意味を有する。)で示されるオキサゾリン類の製造法
を提供するものである。
Means for Solving the Problems The present invention is represented by the general formula 3 R 1 -CN (In the formula, R 1 represents an optionally substituted alkyl group or an aralkyl group or an aryl group.) Nitriles and general formula 2 (In the formula, R 2 , R 3 , R 4 and R 5 are the same or different and each represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group or an aryl group). With a Lewis acid and a molecular sieve in the presence of the general formula 1 (Wherein R 1 , R 2 , R 3 , R 4 and R 5 have the same meanings as described above), and a method for producing the oxazolines.

【0006】本発明における目的化合物および各反応原
料は、それぞれ上記一般式1、2および3で表される
が、これら一般式において、アルキル基としてはメチル
基、エチル基、n−プロピル基、イソプロピル基、n−
ブチル基、イソブチル基、t−ブチル基、n−アミル
基、ネオペンチル基、n−ヘキシル基、シクロヘキシル
基、n−オクチル基、n−ノニル基などが、アラルキル
基としてはベンジル基、2−フェニルエチル基、2−ナ
フチルエチル基、ジフェニルメチル基などが、アリール
基としてはフェニル基、ナフチル基、ビフェニル基、フ
リル基、チオフェニル基などがそれぞれ例示され、これ
らの基がさらに置換基で置換されている場合の置換基と
しては、クロル、ブロムなどのハロゲン原子、メチル
基、エチル基、イソプロピル基、n−ブチル基、t−ブ
チル基、n−アミル基、n−ヘキシル基などの低級アル
キル基、メトキシ基、エトキシ基、n−プロポキシ基、
t−ブトキシ基などの低級アルコキシル基、フェノキシ
基などのアリールオキシ基、n−プロピルチオ基、t−
ブチルチオ基などの低級アルキルチオ基、フェニルチオ
基などのアリールチオ基、ニトロ基、水酸基などが例示
される。
The target compound and each reaction raw material in the present invention are represented by the above-mentioned general formulas 1, 2 and 3, respectively. In these general formulas, the alkyl group is methyl, ethyl, n-propyl or isopropyl. Group, n-
A butyl group, an isobutyl group, a t-butyl group, an n-amyl group, a neopentyl group, an n-hexyl group, a cyclohexyl group, an n-octyl group, an n-nonyl group and the like, and an aralkyl group is a benzyl group, 2-phenylethyl group. Group, 2-naphthylethyl group, diphenylmethyl group, etc., and the aryl group is exemplified by phenyl group, naphthyl group, biphenyl group, furyl group, thiophenyl group, etc., and these groups are further substituted with a substituent. In this case, as the substituent, a halogen atom such as chlorine and bromine, a lower alkyl group such as a methyl group, an ethyl group, an isopropyl group, an n-butyl group, a t-butyl group, an n-amyl group and an n-hexyl group, a methoxy group. Group, ethoxy group, n-propoxy group,
Lower alkoxyl group such as t-butoxy group, aryloxy group such as phenoxy group, n-propylthio group, t-
Examples thereof include lower alkylthio groups such as butylthio group, arylthio groups such as phenylthio group, nitro group and hydroxyl group.

【0007】これら各反応原料の具体的化合物として、
一般式3で示されるニトリル類としては、たとえばアセ
トニトリル、n−プロピオニトリル、n−ブチロニトリ
ル、2−クロロ−n−ブチロニトリル、シクロヘキサン
カルボニトリル、ベンゾニトリル、αートルニトリル、
p−ニトロベンゾニトリルなどが、一般式2で示される
アミノアルコール類としては、たとえば2−アミノエタ
ノール、1−アミノ−2−プロパノール、2−アミノ−
3−メチル−1−ブタノール、フェニルグリシノール、
フェニルアラニノール、2−アミノ−1,2−ジフェニ
ルエタノール、イソロイシノール、バリノール、ノルエ
フェドリン、2−アミノ−(4−メトキシフェニル)−
1−プロパノール、2−アミノ−(4−クロロフェニ
ル)−1−プロパノール、3−フェノキシ−2−アミノ
−1−プロパノールなどがそれぞれ挙げられ、これらア
ミノアルコール類は前記一般式2における置換基R2
4 、または/およびR3 とR5 が異なる場合に、該化
合物はラセミ体であってもよいし光学活性体であっても
よい。
As specific compounds of each of these reaction raw materials,
Examples of the nitriles represented by the general formula 3 include acetonitrile, n-propionitrile, n-butyronitrile, 2-chloro-n-butyronitrile, cyclohexanecarbonitrile, benzonitrile, α-tolunitrile,
Examples of amino alcohols represented by the general formula 2 include p-nitrobenzonitrile and the like, such as 2-aminoethanol, 1-amino-2-propanol, and 2-amino-.
3-methyl-1-butanol, phenylglycinol,
Phenylalaninol, 2-amino-1,2-diphenylethanol, isoleucinol, valinol, norephedrine, 2-amino- (4-methoxyphenyl)-
1-propanol, 2-amino- (4-chlorophenyl) -1-propanol, 3-phenoxy-2-amino-1-propanol and the like can be mentioned respectively, and these amino alcohols can be substituted with the substituent R 2 in the general formula 2 and When R 4 or / and R 3 and R 5 are different, the compound may be a racemate or an optically active form.

【0008】この反応に使用されるルイス酸としては、
アルミニウムトリクロライド、ボロントリフルオライ
ド、塩化亜鉛、塩化鉄、臭化鉄、塩化スズ、アルミニウ
ムトリイソプロポキシド、酢酸亜鉛などが例示される。
かかるルイス酸の使用量は、原料であるアミノアルコー
ル類に対して、通常0.01〜10モル倍、好ましくは
0.1〜3モル倍の範囲である。
The Lewis acid used in this reaction is
Examples include aluminum trichloride, boron trifluoride, zinc chloride, iron chloride, iron bromide, tin chloride, aluminum triisopropoxide, zinc acetate and the like.
The amount of such Lewis acid used is usually in the range of 0.01 to 10 mole times, preferably 0.1 to 3 mole times, relative to the amino alcohols as the raw material.

【0009】また、モレキュラーシーブとしては、ビー
ズ状やペレット状の3A、4A、5Aなどの通常脱水剤
として使用されているものが使用され、その使用量は反
応系中の水分量によっても異なるが、通常は原料である
アミノアルコール類に対して0.01〜100重量倍、
好ましくは0.5〜10重量倍の範囲である。
As the molecular sieve, those which are usually used as a dehydrating agent such as beads or pellets 3A, 4A, 5A are used, and the amount thereof varies depending on the amount of water in the reaction system. , Usually 0.01 to 100 times the weight of the raw material amino alcohol,
It is preferably in the range of 0.5 to 10 times by weight.

【0010】この反応における原料ニトリル類とアミノ
アルコール類との使用割合は、モル比として通常0.5
〜3:1好ましくは0.5〜2:1であり、これら原料
化合物が水分を含んでいても何ら差し支えない。反応は
通常溶媒中で行われ、溶媒としてはトルエン、キシレ
ン、ヘキサン、オクタン、クロルベンゼンなどのルイス
酸を用いる反応に不活性な溶媒が使用されるが、原料ニ
トリル類の種類によっては該ニトリル類自体を溶媒とし
て、あるいはこれら溶媒と混合して使用することもで
き、この場合にはニトリル類は前記した使用範囲を越え
て溶媒量使用される。
In this reaction, the starting nitriles and amino alcohols are usually used in a molar ratio of 0.5.
˜3: 1, preferably 0.5 to 2: 1, and there is no problem even if these raw material compounds contain water. The reaction is usually carried out in a solvent, and an inert solvent is used in the reaction using a Lewis acid such as toluene, xylene, hexane, octane, or chlorobenzene as a solvent. It may be used as a solvent itself or as a mixture with these solvents. In this case, the nitriles are used in a solvent amount beyond the above-mentioned use range.

【0011】反応温度は50〜250℃、好ましくは6
0〜150℃の範囲であり、反応時間は特に制限され
ず、原料のアミノアルコール類の消失したときを反応の
終点とすることができる。
The reaction temperature is 50 to 250 ° C., preferably 6
The reaction time is in the range of 0 to 150 ° C., and the reaction time is not particularly limited, and the end point of the reaction can be the time when the amino alcohol as a raw material disappears.

【0012】反応終了後、ろ過等によってモレキュラー
シーブを除去し、たとえばろ液に飽和炭酸水素ナトリウ
ム水溶液などのアルカリ水溶液を加え、析出する固体を
ろ過等によって除去したのちこれを濃縮し、これに水を
加えたのちトルエン、酢酸エチル、ジエチルエーテル、
ジクロルメタンなどの有機溶媒で抽出し、有機層を濃縮
することにより目的化合物を単離することができ、さら
に必要あれば蒸留やカラムクロマトなどによってこれを
精製することもできる。
After completion of the reaction, the molecular sieves are removed by filtration or the like, and an alkaline aqueous solution such as a saturated sodium hydrogencarbonate aqueous solution is added to the filtrate, the precipitated solid is removed by filtration or the like, and then concentrated, and water is added thereto. After adding toluene, ethyl acetate, diethyl ether,
The target compound can be isolated by extracting with an organic solvent such as dichloromethane and concentrating the organic layer, and if necessary, it can be purified by distillation or column chromatography.

【0013】かくして、一般式1で示されるオキサゾリ
ン類、たとえば2−メチル−4−フェニルオキサゾリ
ン、5−メチル−2−フェニル−2−オキサゾリン、2
−エチル−4−フェニル−5−メチルオキサゾリン、2
−フェニル−4−t−ブチル−5−エチルオキサゾリ
ン、2−ベンジル−4−t−ブチル−5−オキサゾリ
ン、2−プロピル−4−エチル−5,5−ジメチルオキ
サゾリン、2−メチル−4−イソプロピルオキサゾリン
などが製造され、原料であるアミノアルコール類がラセ
ミ体あるいは光学活性体である場合には、該原料に対応
したラセミあるいは光学活性なオキサゾリン類が得られ
る。
Thus, the oxazolines represented by the general formula 1, for example, 2-methyl-4-phenyloxazoline, 5-methyl-2-phenyl-2-oxazoline, 2
-Ethyl-4-phenyl-5-methyloxazoline, 2
-Phenyl-4-t-butyl-5-ethyloxazoline, 2-benzyl-4-t-butyl-5-oxazoline, 2-propyl-4-ethyl-5,5-dimethyloxazoline, 2-methyl-4-isopropyl When oxazoline or the like is produced and the starting amino alcohol is a racemate or an optically active substance, a racemic or optically active oxazoline corresponding to the starting material can be obtained.

【0014】[0014]

【発明の効果】本発明の方法によれば、ニトリル類とア
ミノアルコール類とから一工程で、しかも原料化合物中
に水分が存在していても、予め脱水することなくそのま
ま反応原料として使用することができ、不斉炭素を有さ
ないオキサゾリン類は勿論、ラセミや光学活性なオキサ
ゾリン類も容易に製造することができる。
EFFECTS OF THE INVENTION According to the method of the present invention, nitriles and amino alcohols can be used as a reaction raw material in one step without dehydration in advance even if water is present in the raw material compound. In addition to oxazolines having no asymmetric carbon, racemic and optically active oxazolines can be easily produced.

【0015】[0015]

【実施例】以下、実施例により本発明をさらに詳細に説
明するが、本発明がこれによって限定されるものでない
ことはいうまでもない。
The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited thereto.

【0016】実施例1 (R)−(−)−フェニルグリシノール10(72.9
ミリモル)を4重量%の水を含むアセトニトリル300
gに溶解させ、これにビーズ状のモレキュラーシーブ4
Aを80g加えたのち、30分間窒素気流下に攪拌す
る。この溶液に塩化亜鉛10g(73.4ミリモル)を
加え、加熱還流しながら7時間攪拌する。反応終了後、
反応混合液をろ過してモレキュラーシーブを除去し、分
離したモレキュラーシーブをアセトニトリル(50g×
2)で洗浄する。ろ液と洗液を合わせ、これに飽和炭酸
水素ナトリウム水溶液400gを加え、室温で30分間
攪拌したのち、析出した固体をろ別する。ろ液をほぼア
セトニトリルが除去されるまで濃縮したのち、濃縮液を
400gの水中にあけ、酢酸エチル(300g×2)で
抽出処理を行なう。得られた抽出有機層を100gの水
で洗浄し、無水硫酸ナトリウムで乾燥後濃縮し、濃縮液
をクロロホルム−アセトン(20:1)にてシリカゲル
カラムクロマト精製し、4R−2−メチル−4−フェニ
ルオキサゾリン9.21g(57.2ミリモル)を得
た。 収率 78.5%
Example 1 (R)-(-)-Phenylglycinol 10 (72.9)
Acetonitrile containing 4% by weight of water
g and dissolve it in beaded molecular sieve 4
After adding 80 g of A, the mixture is stirred for 30 minutes under a nitrogen stream. 10 g (73.4 mmol) of zinc chloride is added to this solution, and the mixture is stirred for 7 hours while heating under reflux. After the reaction,
The reaction mixture was filtered to remove the molecular sieves, and the separated molecular sieves were washed with acetonitrile (50 g x
Wash with 2). The filtrate and the washing solution are combined, 400 g of a saturated sodium hydrogen carbonate aqueous solution is added thereto, the mixture is stirred at room temperature for 30 minutes, and the precipitated solid is separated by filtration. After the filtrate is concentrated until almost all the acetonitrile is removed, the concentrated solution is poured into 400 g of water and extracted with ethyl acetate (300 g × 2). The obtained extracted organic layer was washed with 100 g of water, dried over anhydrous sodium sulfate and then concentrated, and the concentrated liquid was purified by silica gel column chromatography with chloroform-acetone (20: 1) and 4R-2-methyl-4-. 9.21 g (57.2 mmol) of phenyloxazoline was obtained. Yield 78.5%

【0017】実施例2 (S)−(+)−2−アミノ−3−メチル−1−ブタノ
ール10(96.9ミリモル)を4重量%の水を含むア
セトニトリル300gに溶解させ、これにビーズ状のモ
レキュラーシーブ4Aを80g加えたのち、30分間窒
素気流下に攪拌する。この溶液に塩化亜鉛10g(7
3.4ミリモル)を加え、加熱還流しながら7時間攪拌
する。反応終了後、実施例1と同様に後処理して4S−
2−メチル−4−イソプロピルオキサゾリン8.75g
(69.1ミリモル)を得た。 収率 71.3%
Example 2 (S)-(+)-2-Amino-3-methyl-1-butanol 10 (96.9 mmol) was dissolved in 300 g of acetonitrile containing 4% by weight of water, and this was dissolved in beads. After 80 g of the molecular sieve 4A was added, the mixture was stirred for 30 minutes under a nitrogen stream. 10 g of zinc chloride (7
(3.4 mmol), and the mixture is stirred with heating under reflux for 7 hours. After completion of the reaction, post-treatment was carried out in the same manner as in Example 1 to obtain 4S-.
2-Methyl-4-isopropyloxazoline 8.75 g
(69.1 mmol) was obtained. Yield 71.3%

【0018】比較例1 モレキュラーシーブを用いないこと以外は実施例1と同
様に反応、後処理(但し、モレキュラーシーブの除去作
用は行わない)して、4R−2−メチル−4−フェニル
オキサゾリン0.551g(3.42ミリモル)を得
た。収率4.7%
Comparative Example 1 4R-2-methyl-4-phenyloxazoline 0 was reacted and worked up in the same manner as in Example 1 except that the molecular sieve was not used, but the molecular sieve was not removed. 0.551 g (3.42 mmol) was obtained. Yield 4.7%

【0019】比較例2 アセトニトリルとして含水率2重量%のアセトニトリル
を使用し、モレキュラーシーブを用いないこと以外は実
施例1と同様に反応、後処理(但し、モレキュラーシー
ブの除去作用は行わない)して、4R−2−メチル−4
−フェニルオキサゾリン1.11g(6.92ミリモ
ル)を得た。収率9.5%
Comparative Example 2 Acetonitrile having a water content of 2% by weight was used as the acetonitrile, and the reaction and post-treatment were carried out in the same manner as in Example 1 except that the molecular sieve was not used (however, the molecular sieve was not removed). 4R-2-methyl-4
-1.11 g (6.92 mmol) of phenyloxazoline was obtained. Yield 9.5%

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式3 R1 −CN (式中、R1 は置換基を有していてもよいアルキル基も
しくはアラルキル基もしくはアリール基を示す。)で示
されるニトリル類と、一般式2 (式中、R2 、R3 、R4 およびR5 は同一または相異
なって水素原子、置換基を有していてもよいアルキル基
もしくはアラルキル基もしくはアリール基を示す。)で
示されるアミノアルコール類とを、ルイス酸およびモレ
キュラーシーブの共存下に反応させることを特徴とする
一般式1 (式中、R1 、R2 、R3 、R4 およびR5 は前記と同
じ意味を有する。)で示されるオキサゾリン類の製造
法。
1. A nitrile represented by the general formula 3 R 1 —CN (wherein R 1 represents an alkyl group which may have a substituent, an aralkyl group or an aryl group) and a general formula 2 (In the formula, R 2 , R 3 , R 4 and R 5 are the same or different and each represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group or an aryl group). With a Lewis acid and a molecular sieve in the presence of the general formula 1 (In the formula, R 1 , R 2 , R 3 , R 4 and R 5 have the same meanings as described above.) A process for producing an oxazoline compound.
JP27347594A 1994-11-08 1994-11-08 Production of oxazolines Pending JPH08134048A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27347594A JPH08134048A (en) 1994-11-08 1994-11-08 Production of oxazolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27347594A JPH08134048A (en) 1994-11-08 1994-11-08 Production of oxazolines

Publications (1)

Publication Number Publication Date
JPH08134048A true JPH08134048A (en) 1996-05-28

Family

ID=17528437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27347594A Pending JPH08134048A (en) 1994-11-08 1994-11-08 Production of oxazolines

Country Status (1)

Country Link
JP (1) JPH08134048A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514422B2 (en) 2002-04-12 2009-04-07 Arena Pharmaceuticals, Inc. 5HT2c receptor modulators
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168624B2 (en) 2004-12-21 2012-05-01 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
CN102898393A (en) * 2012-11-08 2013-01-30 罗梅 Method for synthesizing chiral oxazoline
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514422B2 (en) 2002-04-12 2009-04-07 Arena Pharmaceuticals, Inc. 5HT2c receptor modulators
US8993750B2 (en) 2002-04-12 2015-03-31 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US7977329B2 (en) 2002-04-12 2011-07-12 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US8846906B2 (en) 2002-04-12 2014-09-30 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US8575149B2 (en) 2002-04-12 2013-11-05 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US8546379B2 (en) 2002-04-12 2013-10-01 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US8207158B2 (en) 2002-04-12 2012-06-26 Arena Pharmaceuticals, Inc. 5HT2c receptor modulators
US8273734B1 (en) 2002-04-12 2012-09-25 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US9102627B2 (en) 2003-06-17 2015-08-11 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8404675B2 (en) 2003-06-17 2013-03-26 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
US8946207B2 (en) 2003-06-17 2015-02-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8980881B2 (en) 2004-12-21 2015-03-17 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
US8168624B2 (en) 2004-12-21 2012-05-01 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
US8697686B2 (en) 2004-12-21 2014-04-15 Arena Pharmaceuticals, Inc. Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1H-3-benzazepine hydrochloride
US8546378B2 (en) 2004-12-23 2013-10-01 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8501935B2 (en) 2006-04-03 2013-08-06 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8802845B2 (en) 2006-04-03 2014-08-12 Arena Phamaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US9770455B2 (en) 2010-09-01 2017-09-26 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US10463676B2 (en) 2010-09-01 2019-11-05 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
CN102898393A (en) * 2012-11-08 2013-01-30 罗梅 Method for synthesizing chiral oxazoline

Similar Documents

Publication Publication Date Title
Risgaard et al. Catalytic asymmetric Henry reactions of silyl nitronates with aldehydes
JPH08134048A (en) Production of oxazolines
CN110099893B (en) Preparation method of droxidopa and intermediate thereof
CN109718851B (en) Chiral quaternary phosphonium salt phase transfer catalyst and preparation method and application thereof
DE60102825T2 (en) KINETIC RACEMATING OF CHIRALER 2 AND 3 SUBSTITUTED CARBOXYLIC ACIDS
CN109503670B (en) Chiral monophosphine ligand WJ-Phos of ferrocene skeleton, preparation method and application
CN111440205A (en) Biboric acid diol ester, preparation method thereof, intermediate thereof and application thereof
KR101871567B1 (en) METHOD FOR SYNTHESIZING β-AMINO-DITHIOESTER COMPOUND AND β-AMINO-DITHIOESTER COMPOUND SYNTHESIZED BY THE METHOD
CN115197145B (en) Chiral spiro ammonium salt compound and preparation method and application thereof
JP7363805B2 (en) Method for producing orotic acid derivatives
CN113121401B (en) N-substituted carbonyl fluorosulfonamide compound, preparation method and application thereof
JP2007523098A (en) Catalytic asymmetric synthesis of optically active α-halo-carbonyl compounds
CN114989063A (en) Synthesis method of beta-halopyrrole compound
CN103702981B (en) The manufacture method of optical activity 2-methylproline derivative
CN108610306B (en) Synthetic method of 2H-1, 4-thiazine-3 (4H) -ketone derivative
WO2021002407A1 (en) Fluoroalkyl group-containing compound and production method therefor
CN108503600B (en) Polysubstituted quinoxaline derivative and preparation method thereof
EP2065371A1 (en) Chiral organic catalysts for the stereoselective reduction of carbon-nitrogen double bonds for the preparation of enantiomerically enriched amines
JPWO2004031163A1 (en) Process for producing optically active α-substituted cysteine or a salt thereof, synthetic intermediate thereof and process for producing the same
JP3547590B2 (en) Asymmetric zirconium catalyst
JPH05503718A (en) Method for dividing optically isomeric hydantoin
JP3855295B2 (en) Method for producing bisoxazolines
JPWO2005058805A1 (en) Method for producing optically active amine compound
CN103275126A (en) Method for stereo-selectively synthesizing 3-site phosphorylation indole
JP4689801B2 (en) Method for producing aminothiazole derivative